Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties

被引:53
作者
Kommera, Harish [1 ]
Kaluderovic, Goran N. [1 ,2 ,3 ]
Kalbitz, Jutta [4 ]
Draeger, Birgit [5 ]
Paschke, Reinhard [1 ]
机构
[1] Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany
[2] Univ Belgrade, Dept Chem, Inst Chem Technol & Met, Belgrade 11000, Serbia
[3] Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Germany
[4] BioSolut Halle GmbH, D-06120 Halle, Germany
[5] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany
关键词
Betulinic acid; Betulonic acid; Antitumoral activity; Apoptosis; Cell cycle; ACID INDUCES APOPTOSIS; BETULINIC ACID; CELL-LINES; NEUROECTODERMAL TUMORS; IN-VITRO; AGENTS; CANCER; CYTOTOXICITY; ANTIMALARIAL; MITOCHONDRIA;
D O I
10.1016/j.ejmech.2010.04.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present investigations five new derivatives of betulinic and betulonic acid were synthesized and the effect of this structural variations on anticancer activity was studied and discussed. The antiproliferative activity of betulinic and betulonic acid derivatives was studied against eight tumor cell lines of different histogenic origin. The derivatives exerted a dose dependent antiproliferative action at micromolar concentrations toward target tumor cell lines. The apoptotic mode of cell death on colon cancer cell line HT-29 was induced by the most active compounds 5, 2-amino-3-hydroxy-2-(hydroxymethyl)propyl (3-O-acetyl)betulinate, and 9, 2-amino-3-hydroxy-2-(hydroxymethyl)propyl betulonate. Treatment of HT-29 cells with 5 and 9 induced apoptosis, as observed by dye exclusion test (trypan blue) and by the appearance of a typical ladder pattern in the DNA fragmentation assay and FITC annexin V assay. Cell cycle perturbations caused by compound 5 are also presented. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3346 / 3353
页数:8
相关论文
共 29 条
  • [11] Betulinic acid as new activator of NF-κB:: molecular mechanisms and implications for cancer therapy
    Kasperczyk, H
    La Ferla-Brühl, K
    Westhoff, MA
    Behrend, L
    Zwacka, RM
    Debatin, KM
    Fulda, S
    [J]. ONCOGENE, 2005, 24 (46) : 6945 - 6956
  • [12] Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types
    Kessler, Jan H.
    Mullauer, Franziska B.
    de Roo, Guido M.
    Medema, Jan Paul
    [J]. CANCER LETTERS, 2007, 251 (01) : 132 - 145
  • [13] p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ
    Meng, RD
    El-Deiry, WS
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 262 (02) : 154 - 169
  • [14] TUMOR INHIBITORS .1. PRELIMINARY INVESTIGATION OF ANTITUMOR ACTIVITY OF SARRACENIA-FLAVA
    MILES, DH
    KOKPOL, U
    ZALKOW, LH
    STEINDEL, SJ
    NABORS, JB
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (04) : 613 - 615
  • [15] OGURA M, 1977, LLOYDIA, V40, P157
  • [16] RECIO MD, 1995, PLANTA MED, V61, P9, DOI 10.1055/s-2006-957988
  • [17] Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent
    Salti, GI
    Kichina, JV
    Das Gupta, TK
    Uddin, S
    Bratescu, L
    Pezzuto, JM
    Mehta, RG
    Constantinou, AI
    [J]. MELANOMA RESEARCH, 2001, 11 (02) : 99 - 104
  • [18] SANDBERG F, 1987, ACTA PHARM SUEC, V24, P253
  • [19] Betulinic acid induces apoptosis in human neuroblastoma cell lines
    Schmidt, ML
    Kuzmanoff, KL
    Ling-Indeck, L
    Pezzuto, JM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) : 2007 - 2010
  • [20] Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
    Selzer, E
    Pimentel, E
    Wacheck, W
    Schlegel, W
    Pehamberger, H
    Jansen, B
    Kodym, R
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (05) : 935 - 940